default author photo

Owen Leddy

Massachusetts Institute of Technology (MIT)

77 Massachusetts Avenue

50 Memorial Drive

Cambridge, MA 02139-4307

United States

SCHOLARLY PAPERS

1

DOWNLOADS

25

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

MEK Inhibition Enhances Presentation of Targetable MHC-I Tumor Antigens in Mutant Melanomas

Number of pages: 65 Posted: 26 Jan 2022
Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, University of California, San Francisco (UCSF), Massachusetts Institute of Technology (MIT), Massachusetts Institute of Technology (MIT), Pfizer Boulder Research & Development, Pfizer Boulder Research & Development, Massachusetts Institute of Technology (MIT), University of California, San Francisco (UCSF) and Massachusetts Institute of Technology (MIT) - Department of Biological Engineering
Downloads 25 (1,385,945)

Abstract:

Loading...

MHC-I, Antigen presentation, immunopeptidomics, Mass Spectrometry, kinase inhibitor, melanoma